GlassScriptPhysician profile
Brooke A Lucas
NPI 1134359649
$2,277.50
in general payments reported to CMS, 2019-2025
35 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $150 · 2021: $299 · 2022: $533 · 2023: $433 · 2024: $451 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,081.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $319.85 | 2019-2024 | |
| Hologic Sales and Service, LLC | $279.59 | 2019-2025 | Coolseal Generator, Novasure, Acessa Provu System |
| Mayne Pharma Commercial LLC | $195.02 | 2021-2025 | |
| Aspira Women'S Health INC | $177.35 | 2021-2023 | Ova1 |
| Sage Therapeutics, LLC | $131.84 | 2023-2025 | Zurzuvae |
| Organon LLC | $125.68 | 2022-2024 | Nexplanon |
| Axonics, INC. | $116.24 | 2024 | Bulkamid, Axonics |
| Myovant Sciences INC. | $93.33 | 2022 | |
| Exeltis, USA INC. | $86.83 | 2019-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $77.73 | 2020-2023 | |
| Sumitomo Pharma America, INC. | $76.71 | 2023-2024 | Myfembree |
| Therapeuticsmd, INC. | $67.72 | 2020-2022 | |
| Smith+Nephew, INC. | $59.22 | 2020-2025 | Pico 7 |
| Mylan Pharmaceuticals INC. | $46.20 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $44.96 | 2020-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $35.81 | 2023 | Myrisk |
| Mimedx Group, INC. | $32.20 | 2024 | |
| Daiichi Sankyo INC. | $25.91 | 2024 | Vanflyta |
| Medtronic, INC. | $24.63 | 2023 | Truclear |
| Ethicon US, LLC | $24.24 | 2019 | |
| Agile Therapeutics, INC. | $23.42 | 2021 | |
| Millicent US INC | $21.70 | 2025 | Femlyv |
| Pfizer INC. | $20.18 | 2023 | |
| Astellas Pharma US INC | $18.84 | 2025 | Veozah |
| Lupin INC. | $18.44 | 2019 | |
| Evofem Biosciences, INC. | $17.67 | 2021 | |
| Exact Sciences Corporation | $16.97 | 2024 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $15.22 | 2019 | |
| Shield Therapeutics INC | $14.03 | 2024 | |
| Gynesonics, INC. | $13.23 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Lsi Solutions INC | $12.57 | 2022 | |
| Medicem INC. | $12.50 | 2020 | |
| Duchesnay USA Incorporated | $11.69 | 2019 | |
| Mission Pharmacal Company | $10.87 | 2019 | |
| Meditrina | $9.11 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.